Brief: Cytrx corp says Nasdaq has granted co's request for a continued listing
16/10/2017 23:24
Oct 16 (Reuters) - Cytrx Corp CYTR.O :
* Cytrx corp - Nasdaq has granted co's request for a
continued listing pending results of a stockholder vote on or
before October 30, 2017
Source text for Eikon: ID:nPn5YylKLa
Further company coverage: CYTR.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C